Prognostic value of Laminin-5 in serous adenocarcinomas of the ovary

被引:1
|
作者
Kohlberger, P
Muller-Klingspor, V
Heinzl, A
Obermair, A
Breitenecker, G
Leodolter, S
机构
[1] Univ Vienna, Sch Med, Dept Gynecol & Obstet, A-1090 Vienna, Austria
[2] Univ Vienna, Sch Med, Dept Med Comp Sci Clin BIometr, A-1090 Vienna, Austria
[3] Univ Vienna, Sch Med, Dept Clin Pathol, Gynecopathol Unit, A-1090 Vienna, Austria
[4] Univ Vienna, Sch Med, Ludwig Boltzmann Inst Gynecol Oncol, A-1090 Vienna, Austria
关键词
immunohistochemistry; Laminin; ovarian cancer;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The basement membrane is the first structural barrier that carcinoma cells must penetrate to pass from one compartment to another. In serous papillary cystadenocarcinoma of the ovary, Laminin alpha1, beta2, beta3 and gamma2 chains are present in about 50% of the neoplastic tissue. The aim of the present study was to evaluate the prognostic significance of the expression of Laminin in patients suffering from malignant serous surface epithelial-stromal tumors of the ovary. Patients and Methods: Seventy tumor tissue specimens of consecutive patients treated by surgery between 1985 and 1995 for ovarian cancer, FIGO stages I-TV, were investigated by immunohistochemical methods. Results: Sixteen tumors (22.9%) showed immunohistochemical staining of the cytoplasm and 55 (78.6%) staining of the basement membrane in neoplastic tissue. In multivariate analysis, basement membrane staining of Laminin showed a statistically significant influence with reduced overall survival (p=0.029). Conclusion: The search for additional prognostic factors in ovarian cancer patients is still ongoing. The basement membrane staining of Laminin in malignant serous epithelial tumors of the ovary has been found to be valuable for further investigation.
引用
收藏
页码:3541 / 3544
页数:4
相关论文
共 50 条
  • [21] Processing of laminin-5 in keratinocyte migration
    Veitch, DP
    McGowan, K
    Findell, P
    Sharma, P
    Marinkovich, MP
    MOLECULAR BIOLOGY OF THE CELL, 2000, 11 : 47A - 47A
  • [22] Pancreatic carcinomas deposit laminin-5, preferably adhere to laminin-5, and migrate on the newly deposited basement membrane
    Tani, T
    Lumme, A
    Linnala, A
    Kivilaakso, E
    Kiviluoto, T
    Burgeson, RE
    Kangas, L
    Leivo, I
    Virtanen, I
    AMERICAN JOURNAL OF PATHOLOGY, 1997, 151 (05): : 1289 - 1302
  • [23] The prognostic and predictive value of syntactic structure analysis in serous carcinoma of the ovary
    Palmer, Julia E.
    Cassia, Louis J. Sant
    Irwin, Clive J.
    Morris, A. G.
    Janssen, Emiel A. M.
    Baak, Jan P.
    Rollason, Terence P.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2008, 27 (02) : 191 - 198
  • [24] Laminin-5 expression in melanocytic lesions of the skin
    Ramirez, JA
    Wang, K
    Rao, MS
    Diaz, L
    MODERN PATHOLOGY, 2003, 16 (01) : 98A - 98A
  • [25] Laminin-5 is a component of preserved amniotic membrane
    Kurpakus-Wheater, M
    CURRENT EYE RESEARCH, 2001, 22 (05) : 353 - 357
  • [26] Biological and clinical relevance of Laminin-5 in cancer
    Giannelli, G
    Antonaci, S
    CLINICAL & EXPERIMENTAL METASTASIS, 2001, 18 (06) : 439 - 443
  • [27] Laminin-5 is a biomarker of invasiveness in cervical adenocarcinoma
    Johji Imura
    Yoshiaki Uchida
    Kazuhiro Nomoto
    Kazuhito Ichikawa
    Shigeki Tomita
    Tatsuo Iijima
    Takahiro Fujimori
    Diagnostic Pathology, 7
  • [28] Laminin-5 inhibits human keratinocyte migration
    OToole, EA
    Marinkovich, MP
    Hoeffler, WK
    Furthmayr, H
    Woodley, DT
    EXPERIMENTAL CELL RESEARCH, 1997, 233 (02) : 330 - 339
  • [29] Laminin-5 is a biomarker of invasiveness in cervical adenocarcinoma
    Imura, Johji
    Uchida, Yoshiaki
    Nomoto, Kazuhiro
    Ichikawa, Kazuhito
    Tomita, Shigeki
    Iijima, Tatsuo
    Fujimori, Takahiro
    DIAGNOSTIC PATHOLOGY, 2012, 7
  • [30] Laminin-5 as a marker of invasiveness in cervical lesions
    Skyldberg, B
    Salo, S
    Eriksson, E
    Aspenblad, U
    Moberger, B
    Tryggvason, K
    Auer, G
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (21) : 1882 - 1887